| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Therapeuticsmd, Inc. (TXMD) has 4 insiders with recent SEC Form 4 filings, including 8 buys and 7 sells. TXMD is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 67.5K | $133.6K | - | |
| ? | 23.2K | $45.9K | - | |
| ? | 8.5K | $16.8K | - | |
| ? | 8.5K | $16.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2018 | Bernick Brian | Director | Sale+OE | 182,800 | $6.30 | $1,151,640.00 | -1.4% | |
| Sep 11, 2018 | Milligan John C.K. IV | President/ Secretary | Sale+OE | 250,000 | $6.10 | $1,523,875.00 | -7.8% | |
| Sep 7, 2018 | Finizio Robert G | CEO | Sale+OE | 184,000 | $6.24 | $1,147,240.00 | -0.5% | |
| Aug 21, 2018 | Thompson Tommy G50 | Director | Buy | 4,000 | $5.53 | $22,100.00 | +0.6% | |
| Dec 8, 2017 | Thompson Tommy G50 | Director | Buy | 5,000 | $6.21 | $31,050.00 | +0.7% | |
| Aug 30, 2017 | Thompson Tommy G50 | Director | Buy | 5,000 | $5.99 | $29,950.00 | +0.7% | |
| Mar 11, 2016 | Collins Cooper C. | Director | Buy | 16,000 | $6.23 | $99,716.80 | +80.0% | |
| Aug 25, 2015 | Russell Angus C. | Director | Buy | 13,500 | $5.98 | $80,784.00 | +38.6% | |
| Aug 20, 2015 | Thompson Tommy G50 | Director | Buy | 10,798 | $6.29 | $67,961.53 | +898.3% | |
| Jun 8, 2015 | Krassan Mitchell | EVP, Chief Strategy Officer | Sale+OE | 30,000 | $8.18 | $245,400.00 | -100% |